NEW YORK; January 29, 2013 – Accenture (NYSE:ACN) has been positioned as a Leader in an IDC Health Insights vendor assessment covering IT outsourcing (ITO) across the life sciences sales & marketing industry.
The report, “IDC MarketScape: Worldwide Life Science Sales and Marketing ITO 2013 Vendor Assessment (#HI243591), provides an assessment of the life science sales & marketing industry and market trends, comparing major vendors and assesses the criteria that are most important for life science companies to consider when selecting a service provider.
For the purposes of this analysis, IDC divided potential key measures for success into two primary categories: capabilities and strategies. The assessment includes client references. IDC Health Insights evaluated 14 vendors for this assessment.
“Life sciences sales and marketing organizations are facing unparalleled challenges in building new sales and marketing models – ones that are easily scalable and able to reach a broader set of customers through a wide range of channels at a significantly reduced cost,” said Anne O’Riordan, global senior managing director, Accenture Life Sciences. “This assessment by IDC Health Insights authenticates the depth of our work with life sciences companies to create and operate more efficient, effective sales and marketing models that can shrink operating costs, increase sales and marketing capabilities, and drive revenue.”
In naming Accenture as a Leader, the IDC MarketScape stated, ““Accenture has a strong track record of engaging with its clients under flexible pricing contracts (i.e., profit or risk sharing), which should provide it increasing opportunities going forward as the life science industry continues to become more interested in these types of arrangements and migrate toward this model.”
Accenture was also recently positioned as a Leader in the IDC MarketScape: Worldwide Life Science Sales and Marketing Strategic Consulting 2013 Vendor Assessment (#HI244309).
|Source: IDC Health Insights, 2013
The IDC MarketScape Capabilities score measures vendor product, go-to-market and business execution in the short-term. The Strategy score measures alignment of vendor strategies with customer requirements in a 3-5-year timeframe. Vendor market share is represented by the size of the circles. Vendor year-over-year growth rate relative to the given market is indicated by a plus, neutral or minus next to the vendor name.
Click here to learn more about Accenture’s Life Sciences practice.
About IDC MarketScape
IDC MarketScape vendor analysis model is designed to provide an overview of the competitive fitness of IT, telecommunications, or industry-specific suppliers in a given market. The research methodology utilizes a rigorous scoring methodology based on both qualitative and quantitative criteria that results in a single graphical illustration of each vendor’s position within a given market. IDC MarketScape provides a clear framework in which the product and service offerings, capabilities and strategies, and current and future market success factors of IT, telecommunications, or industry-specific vendors can be meaningfully compared. The framework also provides technology buyers with a transparent foundation to allow companies to independently compare the strengths and weaknesses of current and prospective vendors.
Accenture is a global management consulting, technology services and outsourcing company, with approximately 281,000 people serving clients in more than 120 countries. Combining unparalleled experience, comprehensive capabilities across all industries and business functions, and extensive research on the world’s most successful companies, Accenture collaborates with clients to help them become high-performance businesses and governments. The company generated net revenues of US$28.6 billion for the fiscal year ended Aug. 31, 2013. Its home page is www.accenture.com.
+ 312 693 5992